Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.UK-based Immunodiagnostic Systems Holdings, a manufacturer and distributor of medical diagnostic products, has concluded the sale of IDS Biocode Hycel's hematology business to US-based Escalon Medical.
Subscribe to our email newsletter
Escalon Medical has acquired Immunodiagnostic Systems Holdings’s (IDS’s) hematology business for E4.2 million which is being remitted over a period of 48 months from the completion date of December 31, 2008.
The directors believe that the disposal of this business will allow the group to focus on its main activities of manual immunoassay production and the launch of the new automated analyser, the IDS iSYS.
According to IDS, this disposal will also lead to increased profits of the company as the hematology business is loss-making. The funds, as and when received, will be used to reduce the company’s net debt and improve working capital.